
AstraZeneca–Bristol Myers $400B Merger Talks Rock Pharma—and Fizzle Out
Reports of a record-breaking pharma tie-up sent shares tumbling before a senior source denied the talks, exposing investor skepticism and strategic tensions.
Aug 5, 20260 views

Reports of a record-breaking pharma tie-up sent shares tumbling before a senior source denied the talks, exposing investor skepticism and strategic tensions.

As Eli Lilly surges and Amazon Pharmacy enters the fray, Novo Nordisk fights back with global expansion and deep cost cuts.

Generic versions of a new daily pill could cost as low as $5 per person per year, but access in Latin America remains uncertain.